Other

Accrued liabilities

Xylem Accrued liabilities remained flat by 0.0% to -$17.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 505.9%, from $4.25M to -$17.25M. Over 4 years (FY 2021 to FY 2025), Accrued liabilities shows a downward trend with a 77.2% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025Feb 25, 2026

How to read this metric

Fluctuations reflect changes in the timing of operational expense recognition and payment cycles.

Detailed definition

This represents the net change in short-term obligations for expenses that have been incurred but not yet invoiced or pa...

Peer comparison

Standard line item in the operating section of the cash flow statement.

Metric ID: other_increase_decrease_in_accrued_liabilities

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$7.00M$57.00M-$4.00M$17.00M-$69.00M
YoY Change+714.3%-107.0%+525.0%-505.9%
Range-$69.00M$57.00M
CAGR+77.2%
Avg YoY Growth+156.6%
Median YoY Growth+209.0%

Frequently Asked Questions

What is Xylem's accrued liabilities?
Xylem (XYL) reported accrued liabilities of -$17.25M in Q4 2025.
How has Xylem's accrued liabilities changed year-over-year?
Xylem's accrued liabilities decreased by 505.9% year-over-year, from $4.25M to -$17.25M.
What is the long-term trend for Xylem's accrued liabilities?
Over 4 years (2021 to 2025), Xylem's accrued liabilities has grown at a 77.2% compound annual growth rate (CAGR), from $7.00M to -$69.00M.
What does accrued liabilities mean?
The net change in short-term obligations for expenses incurred but not yet paid.